Research / DT / Fundamental state Inspectable configuration
State dimensions Filing 0001773383-22-000021 General Corporate
Debt relative to revenue 20th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.debt_to_revenue
126.02% · OPTIONAL · VALID
Capex intensity 30th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.73% · OPTIONAL · VALID
Operating cash generation 60th Own-history percentile · N=10
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
25.27% · OPTIONAL · VALID
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
31.63% · CORE · NOT_ENOUGH_HISTORY
Gross margin 50th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.gross_margin
81.53% · CORE · VALID
Operating margin 40th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.operating_margin
8.81% · CORE · VALID
R&D intensity 70th Own-history percentile · N=10
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
16.98% · OPTIONAL · VALID
SBC intensity 60th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
11.27% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 29 states Self-history eligible
Sep 30, 2021 7/8 normalized Level 3 Dec 31, 2021 7/8 normalized Level 3 Mar 31, 2022 7/8 normalized Level 3 Jun 30, 2022 8/8 normalized Level 3 Sep 30, 2022 8/8 normalized Level 3 Dec 31, 2022 7/7 normalized Level 3 Mar 31, 2023 7/7 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2023 7/7 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 7/7 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 7/7 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 7/7 normalized Level 3 Mar 31, 2026 7/7 normalized Level 3 Jun 30, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 147.07%
Current 126.02%
Delta -21.05% Capex Intensity Decreased
Previous 2.06%
Current 1.73%
Delta -0.33% Cash Generation Increased
Previous 8.08%
Current 25.27%
Delta 17.19% Growth Decreased
Previous 34.27%
Current 31.63%
Delta -2.64% Margin Decreased
Previous 81.59%
Current 81.53%
Delta -0.06% Profitability Decreased
Previous 9.39%
Current 8.81%
Delta -0.58% R And D Intensity Increased
Previous 16.75%
Current 16.98%
Delta 0.23% Sbc Intensity Decreased
Previous 11.30%
Current 11.27%
Delta -0.03% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.